| Old Articles: <Older 3061-3070 Newer> |
|---|
 |
Bio-IT World
Jul/Aug 2006 |
News Blast Protein Powerhouse... Closing the Deal... Financing Completed... Clinphone London IPO...   |
Bio-IT World
Jul/Aug 2006
Kevin Davies |
Beyond the Last Chromosome About 700 attendees gathered Beyond Genome 2006, one of Cambridge Healthtech Institute's flagship conferences, to discuss the major technology trends in postgenomic biology, including systems biology, RNAi, proteomics, and personalized medicine. |
Bio-IT World
Jul/Aug 2006
Mark D. Uehling |
RIP, Data Managers? Do people working in data management at drug discovery firms have a future? |
Bio-IT World
Jul/Aug 2006 |
News Blast Health Solutions... Rna Interference... HIV Triple Combo... |
Bio-IT World
Jul/Aug 2006
John Russell |
Burrill's Biotech 2006 G. Steven Burrill's Biotech 2006 -- Life Sciences: A Changing Prescription is his 20th annual report on the industry. This longtime market watcher and biotech investment banker has pulled together a kind of whirlwind tour of biotech finances, markets, and technologies. |
The Motley Fool
August 4, 2006
Stephen D. Simpson |
Ruling Slows Down Kinetic Concepts Losing a key patent case will become a severe blow for this med-tech company if it isn't overturned on appeal. Investors, beware. |
BusinessWeek
August 14, 2006
Arlene Weintraub |
The Lawyer Is In At Pfizer Jeffrey Kindler's ascent reflects the new challenges drugmakers face. |
BusinessWeek
August 14, 2006
Timothy J. Mullaney |
Business, Heal Health Care "The End of Medicine How Silicon Valley Will Reboot Your Doctor" is a smart, entertaining tour of the labs inventing the future of medicine. |
BusinessWeek
August 14, 2006 |
Statins Could Cause Legal Headaches Pfizer insists that Lipitor's safety record "is very well established." |
The Motley Fool
August 3, 2006
Ryan Fuhrmann |
Cardinal Distributes the Goods The drug wholesaler and distributor has to regain investor confidence and rebuild a track record in a changed industry. So far, so good for 2006. Let's see if any further information can be found once Cardinal submits its 10-K filing to the SEC. |
| <Older 3061-3070 Newer> Return to current articles. |
